Showing items 1 - 2 of 2

Your selections:

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

- Ramakrishnan, Sanjay, Nicolau, Dan V., Bright, Stephen, Butler, Christopher, Cane, Jennifer L., Halner, Andreas, Matthews, Philippa C., Donnelly, Louise E., Simpson, Jodie L., Baker, Jonathan R., Fadai, Nabil T., Peterson, Stefan, Langford, Beverly, Bengtsson, Thomas, Barnes, PJ, Russell, REK, Bafadhel, M, Mahdi, Mahdi, Jeffers, Helen, Mwasuku, Christine, Krassowska, Karolina, Fox, Robin, Binnian, Ian, Glover, Victoria

Patient-Reported outcomes of treatment of opioid dependence with weekly and monthly subcutaneous depot vs daily sublingual buprenorphine: a randomized clinical trial

- Lintzeris, Nicholas, Dunlop, Adrian J., Peterson, Stefan, Tiberg, Fredrik, Haber, Paul S., Lubman, Dan I., Graham, Robert, Hutchinson, Sarah, Arunogiri, Shalini, Hayes, Victoria, Hjelmström, Peter, Svedberg, Agneta

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit